NetworkNewsBreaks

TuesdayJul 31, 2018 9:25 am

NetworkNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) CEO to Convert Loans into Common Shares

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced its plans to convert a total of $805,240.47, the majority of which encompasses loans advanced to the company by Victory Square CEO Shafin Diamond Tejani, into common shares in the capital of the company. The shares would be issued at $1.00 each, representing a premium of 19% per share, as the current market price is $0.84 per share. The conversion is subject to all requisite regulatory approvals and all shares issued shall also be subject to a four month hold period under applicable Canadian securities laws.…

Continue Reading

MondayJul 30, 2018 3:33 pm

NetworkNewsBreaks – Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS) Closes $10M Public Offering

Medigus (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools engaged in direct visualization technology, recently closed an underwritten public offering of 2,837,674 units at a price of $3.50 per unit. Each unit consisted of one American Depositary Share (“ADS”) and one Series C warrant to purchase one ADS. The ADSs and accompanying Series C warrants were purchased together in the offering, but were issued separately. Gross proceeds of approximately $10 million were raised from the offering, which Medigus intends to use for general corporate purposes. To view the full press release, vist http://nnw.fm/5MfiQ About Medigus…

Continue Reading

MondayJul 30, 2018 1:50 pm

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Reports Improved Response Rate to Increased Dosage in HIV Phase 3 Monotherapy Trial

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced that it has received clearance from the independent Institutional Review Board (“IRB”) overseeing its CD03 phase 3 investigative monotherapy trial to increase the weekly PRO 140 dose from 525 mg to 700 mg for newly enrolled patients. The trial’s objective is to evaluate the efficacy, safety and tolerability of PRO 140 as a long-acting, single-agent maintenance therapy for the chronic suppression of HIV. Current participants in the trial that were not able to maintain suppressed HIV viral load on a lower dose of PRO 140 will be allowed to continue in the…

Continue Reading

MondayJul 30, 2018 11:12 am

NetworkNewsBreaks – Pacific Software, Inc. (PFSF) Develops Innovative Trade Portal Utilizing Secure Blockchain Databases

Emerging development technology corporation Pacific Software’s (OTC: PFSF) blockchain technologies have been designed to increase supply chain transparency, increasing consumer confidence. The company intends to use this technology to exploit the booming Brazilian agriculture market. An article discussing the company’s technology reads: “In a world where consumers are increasingly concerned about the origins of their products, blockchain technology will make supply chains more transparent and easier to trace. Large-scale producers will be able to keep better records of their operations, and niche producers, such as organic farmers, will be able to more easily prove and certify every step their products…

Continue Reading

MondayJul 30, 2018 10:40 am

NetworkNewsBreaks – The Flowr Corp. Discusses Company Activities in Interview with New Cannabis Ventures

The Flowr Corp. was the subject of a recent article by New Cannabis Ventures highlighting the company’s activities as it prepares to become publicly-listed. CEO Tom Flow and Chairman of the Board and Chief Strategist Steve Klein provided an exclusive interview with New Cannabis Ventures discussing its strategy to compete in the booming Canadian market. Per the article, the company is currently building its 84,000-square-foot flagship facility in Kelowna, British Columbia, which is expected to be complete by year-end with an annual production capacity of 12,000 to 15,000 kilos. The company is also designing other facilities, which will bring Flowr’s…

Continue Reading

MondayJul 30, 2018 9:33 am

NetworkNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Uplists to the OTCQX Best Market

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced that the company’s Form 211 has been approved by FINRA, and the approval to uplist to the OCTQX Best Market as a foreign issuer, with full Depository Trust Company (“DTC”) eligibility is now in process. Effective today, the company's common shares began trading on the OTCQX under the symbol "PHVAF". Overall, the uplisting will result in added service, value and convenience to USA investors while DTC eligibility streamlines and fast-tracks the settlement process of daily trades. "As a publicly traded company, with US operations, the United States is a critical market…

Continue Reading

FridayJul 27, 2018 3:05 pm

NetworkNewsBreaks – GTX Corp (GTXOD) Offers Two New GPS Tracking Products for Children

GPS technology-focused holding company GTX Corp (OTC: GTXOD) recently released two new GPS products to monitor the location of children. An article discussing the company’s technology reads: “GTXO offers tracking devices and services in a global market, providing smart and wearable GPS tracking products for people and tracking technologies for high value assets through its IoT monitoring platform. … The two newly launched products are GPS trackers for children, toddlers and adults with small feet. The SmartSole size small can be trimmed to fit most children’s shoes, sizes three and above (http://nnw.fm/X7POt). It will also fit up to a women’s…

Continue Reading

FridayJul 27, 2018 3:00 pm

NetworkNewsBreaks – Medical Cannabis Payment Solutions (REFG) Creating Mobile Hemp CBD Processing Service

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) recently partnered with Paper Lantern, LLC to create the nation’s largest mobile hemp CBD processing service. An article discussing the company reads: “These groundbreaking mobile hemp CBD extraction labs will be used at hemp farms owned and operated by REFG, as well as farms that have entered into processing agreements with the company. The labs will offer economic benefits, improved processing efficiency, reduced energy consumption and greater control over product quality, all while eliminating redundant layered costs such as transportation. Farmers and capital partners will gain the competitive edge and…

Continue Reading

FridayJul 27, 2018 11:49 am

NetworkNewsBreaks – Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Seeks Mineral Resources in Argentina

Junior exploration company Marifil Mines (TSX.V: MFM) (OTCQB: MFMLF) is primarily focusing on Argentinean mineral resource acquisitions. An article discussing the company reads: “Global headlines continue to pop up predicting crisis-level shortages of metals like lithium, cobalt and gold. Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), a Vancouver, Canada-based mineral exploration company, is among those answering the call to help meet the world’s demand for these metals. Marifil Mines is engaged in the exploration, evaluation and acquisition of mineral-rich resource properties in Argentina, with its current focus chiefly on lithium, gold and cobalt exploration.” To view the full article, visit…

Continue Reading

FridayJul 27, 2018 11:45 am

NetworkNewsBreaks – Zenosense, Inc.’s (ZENO) MIDS Cardiac™ Device Proves Potential to Saves Lives through Early Detection

Zenosense (OTC: ZENO) recently reported the successful completion of a second round of testing for its MIDS Cardiac™ device, a patented handheld point-of-care (“POC”) technology for the detection of heart attack. An article discussing the device reads: “According to the World Health Organization, early detection is one of the most important prerequisites for the successful management of cardiovascular problems. … With detection equal or superior to state of the art laboratory analyzers and advanced portability allowing it to be used at point of care, including in an emergency setting, MIDS Cardiac™ would be an absolute game changer which could help…

Continue Reading